News & Articles

The FDA cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly 10 years

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing

Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using Euroimmun tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection

Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva

Two new studies reveal how antibodies against the SARS-CoV-2 virus can vary between individuals

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

Novel RHINOstic swab collection device and automated liquid handlers increase testing throughput while decreasing active manpower

The new MDx system will efficiently access a wide array of Seegene's syndromic assays

DNA/RNA Shield – DirectDetect reagent eliminates RNA extraction for rapid deployment of COVID-19 tests

The Mag-Bind Blood & Tissue HDQ Prefilled 96 Kit removes time-consuming reagent preparation procedures necessary for magnetic processor DNA purification

This new software system from Shimadzu Scientific uses multiple, alternating sample introduction streams to keep the mass spectrometer working continuously

The latest discoveries show potential in resolving persistent challenges in healthcare and lab testing for women

Gain insights on topics from point-of-care blood testing, cardiac troponin and biomarker discovery to clinical QC and more

Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year

The kits have been developed based on the traditional PROGEN ELISA kits which have already earned reference standard status in gene therapy centers worldwide

Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more

Thermo Scientific Delta Q IRMS is the first product developed under ground-breaking IsoFootprint initiative to tackle CO₂ emissions for more sustainable science

AMSBIO talks about the release of its new aptamer product range to fight against COVID-19